| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |